Amgen vet Marc de Garidel takes the helm at Corvidia; Peter Greenleaf lands next CEO job at Cerecor; Edward Gudaitis tapped to lead Acerus
→ Amgen vet Marc de Garidel is taking the helm at Corvidia Therapeutics as the biotech wraps up a Phase II trial of its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
